SCHEMBL9378341

SCHEMBL9378341

CC1(C)CC(=O)Nc2cc3nc(-c4cc5ccccc5o4)[nH]c3cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.41
CREBBP Q92793 2/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
AURKA O14965 1/20 0.38
AURKB Q96GD4 1/20 0.38
ADRA2A P08913 2/20 0.37
ALDH1A1 P00352 6/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
TSHR P16473 3/20 0.35
TP53 P04637 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378253 0.81 PDE4A (0.54) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL9377773 0.80 PDE4A (0.45) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9380164 0.80 ESR1 (0.47) BRD4CREBBPNPC1RAB9APDE4A
SCHEMBL9382393 0.80 PDE4A (0.47) BRD4NPC1RAB9APDE4APDE4B
SCHEMBL9703652 0.78 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9385715 0.78 CBFB (0.54) NPC1RAB9AALDH1A1LMNAKDM4E
SCHEMBL9379192 0.77 TOP2A (0.49) BRD4CREBBPNPC1RAB9APDE4A
SCHEMBL9703486 0.76 PDE4A (0.43) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL9702835 0.76 PDE4A (0.41) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL9382509 0.76 PDE5A (0.46) BRD4NPC1RAB9APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0275888-B1 Tricyclic benzimidazoles, process for their preparation and use as medicaments BOEHRINGER MANNHEIM GMBH (DE) 1994-04-06 EP disclosed
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed